Table of Contents Executive Summary 1 Industry Overview of NASH (Non-alcoholic Steatohepatitis) Biomarkers 1.1 Definition of NASH (Non-alcoholic Steatohepatitis) Biomarkers 1.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Segment by Type 1.2.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate Comparison by Types (2014-2025) 1.2.2 Serum biomarkers 1.2.3 Hepatic fibrosis biomarkers 1.2.4 Apoptosis biomarkers 1.2.5 Oxidative stress biomarkers 1.2.6 Others 1.3 NASH (Non-alcoholic Steatohepatitis) Biomarkers Segment by Applications 1.3.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Consumption Comparison by Applications (2014-2025) 1.3.2 Pharma & CRO Industry 1.3.3 Hospitals 1.3.4 Diagnostic Labs 1.3.5 Academic Research Institutes 1.4 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Overall Market 1.4.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue (2014-2025) 1.4.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Production (2014-2025) 1.4.3 North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Status and Prospect (2014-2025) 1.4.4 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Status and Prospect (2014-2025) 1.4.5 China NASH (Non-alcoholic Steatohepatitis) Biomarkers Status and Prospect (2014-2025) 1.4.6 Japan NASH (Non-alcoholic Steatohepatitis) Biomarkers Status and Prospect (2014-2025) 1.4.7 Southeast Asia NASH (Non-alcoholic Steatohepatitis) Biomarkers Status and Prospect (2014-2025) 1.4.8 India NASH (Non-alcoholic Steatohepatitis) Biomarkers Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of NASH (Non-alcoholic Steatohepatitis) Biomarkers 2.3 Manufacturing Process Analysis of NASH (Non-alcoholic Steatohepatitis) Biomarkers 2.4 Industry Chain Structure of NASH (Non-alcoholic Steatohepatitis) Biomarkers 3 Development and Manufacturing Plants Analysis of NASH (Non-alcoholic Steatohepatitis) Biomarkers 3.1 Capacity and Commercial Production Date 3.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of NASH (Non-alcoholic Steatohepatitis) Biomarkers 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 NASH (Non-alcoholic Steatohepatitis) Biomarkers Production and Capacity Analysis 4.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Analysis 4.3 NASH (Non-alcoholic Steatohepatitis) Biomarkers Price Analysis 4.4 Market Concentration Degree 5 NASH (Non-alcoholic Steatohepatitis) Biomarkers Regional Market Analysis 5.1 NASH (Non-alcoholic Steatohepatitis) Biomarkers Production by Regions 5.1.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Production by Regions 5.1.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Regions 5.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Consumption by Regions 5.3 North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Analysis 5.3.1 North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Production 5.3.2 North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Import and Export 5.4 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Analysis 5.4.1 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Production 5.4.2 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Import and Export 5.5 China NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Analysis 5.5.1 China NASH (Non-alcoholic Steatohepatitis) Biomarkers Production 5.5.2 China NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue 5.5.3 Key Manufacturers in China 5.5.4 China NASH (Non-alcoholic Steatohepatitis) Biomarkers Import and Export 5.6 Japan NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Analysis 5.6.1 Japan NASH (Non-alcoholic Steatohepatitis) Biomarkers Production 5.6.2 Japan NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan NASH (Non-alcoholic Steatohepatitis) Biomarkers Import and Export 5.7 Southeast Asia NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Analysis 5.7.1 Southeast Asia NASH (Non-alcoholic Steatohepatitis) Biomarkers Production 5.7.2 Southeast Asia NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia NASH (Non-alcoholic Steatohepatitis) Biomarkers Import and Export 5.8 India NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Analysis 5.8.1 India NASH (Non-alcoholic Steatohepatitis) Biomarkers Production 5.8.2 India NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue 5.8.3 Key Manufacturers in India 5.8.4 India NASH (Non-alcoholic Steatohepatitis) Biomarkers Import and Export 6 NASH (Non-alcoholic Steatohepatitis) Biomarkers Segment Market Analysis (by Type) 6.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Production by Type 6.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Type 6.3 NASH (Non-alcoholic Steatohepatitis) Biomarkers Price by Type 7 NASH (Non-alcoholic Steatohepatitis) Biomarkers Segment Market Analysis (by Application) 7.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Consumption by Application 7.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Consumption Market Share by Application (2014-2019) 8 NASH (Non-alcoholic Steatohepatitis) Biomarkers Major Manufacturers Analysis 8.1 GENFIT SA 8.1.1 GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Sites and Area Served 8.1.2 GENFIT SA Product Introduction, Application and Specification 8.1.3 GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 Gilead Sciences, Inc. (GILD) 8.2.1 Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Sites and Area Served 8.2.2 Gilead Sciences, Inc. (GILD) Product Introduction, Application and Specification 8.2.3 Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 AstraZeneca 8.3.1 AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Sites and Area Served 8.3.2 AstraZeneca Product Introduction, Application and Specification 8.3.3 AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 Novartis AG 8.4.1 Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Sites and Area Served 8.4.2 Novartis AG Product Introduction, Application and Specification 8.4.3 Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 8.5 Bristol-Myers Squibb Company 8.5.1 Bristol-Myers Squibb Company NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Sites and Area Served 8.5.2 Bristol-Myers Squibb Company Product Introduction, Application and Specification 8.5.3 Bristol-Myers Squibb Company NASH (Non-alcoholic Steatohepatitis) Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.5.4 Main Business and Markets Served 8.6 Allergan Plc 8.6.1 Allergan Plc NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Sites and Area Served 8.6.2 Allergan Plc Product Introduction, Application and Specification 8.6.3 Allergan Plc NASH (Non-alcoholic Steatohepatitis) Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.6.4 Main Business and Markets Served 8.7 Novo Nordisk A/S 8.7.1 Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Sites and Area Served 8.7.2 Novo Nordisk A/S Product Introduction, Application and Specification 8.7.3 Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.7.4 Main Business and Markets Served 8.8 Boehringer Ingelheim 8.8.1 Boehringer Ingelheim NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Sites and Area Served 8.8.2 Boehringer Ingelheim Product Introduction, Application and Specification 8.8.3 Boehringer Ingelheim NASH (Non-alcoholic Steatohepatitis) Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.8.4 Main Business and Markets Served 8.9 Pfizer Inc 8.9.1 Pfizer Inc NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Sites and Area Served 8.9.2 Pfizer Inc Product Introduction, Application and Specification 8.9.3 Pfizer Inc NASH (Non-alcoholic Steatohepatitis) Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.9.4 Main Business and Markets Served 9 Development Trend of Analysis of NASH (Non-alcoholic Steatohepatitis) Biomarkers Market 9.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Trend Analysis 9.1.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size (Volume and Value) Forecast 2019-2025 9.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Regional Market Trend 9.2.1 North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Forecast 2019-2025 9.2.2 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Forecast 2019-2025 9.2.3 China NASH (Non-alcoholic Steatohepatitis) Biomarkers Forecast 2019-2025 9.2.4 Japan NASH (Non-alcoholic Steatohepatitis) Biomarkers Forecast 2019-2025 9.2.5 Southeast Asia NASH (Non-alcoholic Steatohepatitis) Biomarkers Forecast 2019-2025 9.2.6 India NASH (Non-alcoholic Steatohepatitis) Biomarkers Forecast 2019-2025 9.3 NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Trend (Product Type) 9.4 NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 NASH (Non-alcoholic Steatohepatitis) Biomarkers Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of NASH (Non-alcoholic Steatohepatitis) Biomarkers Table Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Production (K Units) Growth Rate Comparison by Types (2014-2025) Figure Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Market Share by Types in 2018 Figure Serum biomarkers Product Picture Figure Hepatic fibrosis biomarkers Product Picture Figure Apoptosis biomarkers Product Picture Figure Oxidative stress biomarkers Product Picture Figure Others Product Picture Table Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Consumption (K Units) Comparison by Applications (2014-2025) Figure Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Consumption Market Share by Applications in 2018 Figure Pharma & CRO Industry Figure Hospitals Figure Diagnostic Labs Figure Academic Research Institutes Figure Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue (Million USD) (2014-2025) Figure Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Production (K Units) (2014-2025) Figure North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size (Million USD) (2014-2025) Figure Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size (Million USD) (2014-2025) Figure China NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size (Million USD) (2014-2025) Figure Japan NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size (Million USD) (2014-2025) Figure Southeast Asia NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size (Million USD) (2014-2025) Figure India NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size (Million USD) (2014-2025) Table NASH (Non-alcoholic Steatohepatitis) Biomarkers Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of NASH (Non-alcoholic Steatohepatitis) Biomarkers in 2018 Figure Manufacturing Process Analysis of NASH (Non-alcoholic Steatohepatitis) Biomarkers Figure Industry Chain Structure of NASH (Non-alcoholic Steatohepatitis) Biomarkers Table Capacity and Commercial Production Date of Key Manufacturers Table Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Manufacturing Plants Distribution Table NASH (Non-alcoholic Steatohepatitis) Biomarkers Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table NASH (Non-alcoholic Steatohepatitis) Biomarkers Capacity (K Units) of Major Manufacturers (2014-2019) Table NASH (Non-alcoholic Steatohepatitis) Biomarkers Production (K Units) of Major Manufacturers (2014-2019) Table NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Market Share of Major Manufacturers (2014-2019) Figure NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Share by Manufacturers in 2018 Table NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue (Million US$) of Major Manufacturers (2014-2019) Table NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share of Major Manufacturers (2014-2019) Figure NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Share by Manufacturers in 2018 Table NASH (Non-alcoholic Steatohepatitis) Biomarkers Average Price (USD/Unit) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Production by Regions 2014-2019 (K Units) Table Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Market Share by Regions 2014-2019 Figure Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Market Share by Regions in 2018 Table Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Regions 2014-2019 (Million USD) Table Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Regions 2014-2019 Figure Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Regions in 2018 Table Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Consumption by Regions 2014-2019 (K Units) Table Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Consumption Market Share by Regions 2014-2019 Figure North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate 2014-2019 (K Units) Figure North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth Rate 2014-2019 (Million USD) Table North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Production, Consumption Import and Export (K Units) Figure Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate 2014-2019 (K Units) Figure Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth Rate 2014-2019 (Million USD) Table Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Production, Consumption Import and Export (K Units) Figure China NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate 2014-2019 (K Units) Figure China NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth Rate 2014-2019 (Million USD) Table China NASH (Non-alcoholic Steatohepatitis) Biomarkers Production, Consumption Import and Export (K Units) Figure Japan NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate 2014-2019 (K Units) Figure Japan NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth Rate 2014-2019 (Million USD) Table Japan NASH (Non-alcoholic Steatohepatitis) Biomarkers Production, Consumption Import and Export (K Units) Figure Southeast Asia NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate 2014-2019 (K Units) Figure Southeast Asia NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia NASH (Non-alcoholic Steatohepatitis) Biomarkers Production, Consumption Import and Export (K Units) Figure India NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate 2014-2019 (K Units) Figure India NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth Rate 2014-2019 (Million USD) Table India NASH (Non-alcoholic Steatohepatitis) Biomarkers Production, Consumption Import and Export (K Units) Figure Global Consumption NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Share by Application (2014-2019) Figure Global Value (Consumption) NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Share by Application (2014-2019) Table GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Sites and Area Served Table GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction, Application and Specification Table GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate (2014-2019) Table GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Market Share (2014-2019) Figure GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share (2014-2019) Table GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Main Business and Markets Served Table Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Sites and Area Served Table Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction, Application and Specification Table Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate (2014-2019) Table Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Market Share (2014-2019) Figure Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share (2014-2019) Table Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers Main Business and Markets Served Table AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Sites and Area Served Table AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction, Application and Specification Table AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate (2014-2019) Table AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Market Share (2014-2019) Figure AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share (2014-2019) Table AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Main Business and Markets Served Table Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Sites and Area Served Table Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction, Application and Specification Table Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate (2014-2019) Table Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Market Share (2014-2019) Figure Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share (2014-2019) Table Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Main Business and Markets Served Table Bristol-Myers Squibb Company NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Sites and Area Served Table Bristol-Myers Squibb Company NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction, Application and Specification Table Bristol-Myers Squibb Company NASH (Non-alcoholic Steatohepatitis) Biomarkers Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Bristol-Myers Squibb Company NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate (2014-2019) Table Bristol-Myers Squibb Company NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Market Share (2014-2019) Figure Bristol-Myers Squibb Company NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share (2014-2019) Table Bristol-Myers Squibb Company NASH (Non-alcoholic Steatohepatitis) Biomarkers Main Business and Markets Served Table Allergan Plc NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Sites and Area Served Table Allergan Plc NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction, Application and Specification Table Allergan Plc NASH (Non-alcoholic Steatohepatitis) Biomarkers Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Allergan Plc NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate (2014-2019) Table Allergan Plc NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Market Share (2014-2019) Figure Allergan Plc NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share (2014-2019) Table Allergan Plc NASH (Non-alcoholic Steatohepatitis) Biomarkers Main Business and Markets Served Table Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Sites and Area Served Table Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction, Application and Specification Table Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate (2014-2019) Table Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Market Share (2014-2019) Figure Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share (2014-2019) Table Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Main Business and Markets Served Table Boehringer Ingelheim NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Sites and Area Served Table Boehringer Ingelheim NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction, Application and Specification Table Boehringer Ingelheim NASH (Non-alcoholic Steatohepatitis) Biomarkers Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Boehringer Ingelheim NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate (2014-2019) Table Boehringer Ingelheim NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Market Share (2014-2019) Figure Boehringer Ingelheim NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share (2014-2019) Table Boehringer Ingelheim NASH (Non-alcoholic Steatohepatitis) Biomarkers Main Business and Markets Served Table Pfizer Inc NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Sites and Area Served Table Pfizer Inc NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction, Application and Specification Table Pfizer Inc NASH (Non-alcoholic Steatohepatitis) Biomarkers Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Pfizer Inc NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate (2014-2019) Table Pfizer Inc NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Market Share (2014-2019) Figure Pfizer Inc NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share (2014-2019) Table Pfizer Inc NASH (Non-alcoholic Steatohepatitis) Biomarkers Main Business and Markets Served Figure Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Production (K Units) Growth Rate Forecast 2019-2025 Figure Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Price (USD/Unit) Forecast 2019-2025 Figure North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate Forecast 2019-2025 (K Units) Figure North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate Forecast 2019-2025 (K Units) Figure Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate Forecast 2019-2025 (K Units) Figure China NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate Forecast 2019-2025 (K Units) Figure Japan NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate Forecast 2019-2025 (K Units) Figure Southeast Asia NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate Forecast 2019-2025 (K Units) Figure India NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (K Units) of NASH (Non-alcoholic Steatohepatitis) Biomarkers by Type (2019-2025) Table Global Consumption (K Units) of NASH (Non-alcoholic Steatohepatitis) Biomarkers by Application (2019-2025) Table NASH (Non-alcoholic Steatohepatitis) Biomarkers Distributors List Table NASH (Non-alcoholic Steatohepatitis) Biomarkers Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

GENFIT SA Gilead Sciences, Inc. (GILD) AstraZeneca Novartis AG Bristol-Myers Squibb Company Allergan Plc Novo Nordisk A/S Boehringer Ingelheim Pfizer Inc